Approaching year three of a global pandemic, it’s shocking that the U.S. is still debating whether workers should be allowed to take time off work when they’re sick or ne...
It’s become a popular talking point to list all the risks of data collection, whether it be privacy and surveillance or the lack of transparency that can come with data o...
With unanimous Democratic support and a dozen Republican votes, the Respect for Marriage Act passed the Senate and will soon land on President Joe Biden’s desk, virtuousl...
The strategically vital city of Kherson is back in the hands of Ukrainians, albeit under threat of Russian shelling and attacks on its electricity supply. But as combatan...
Biogen Inc. and Eisai Co. caused a stir in September when they announced positive results in a late-stage trial for a closely watched Alzheimer’s drug, lecanemab. Doctors...
Sleep is finally having its moment. I’m a sleep researcher and clinician, and it’s exhilarating to see broader recognition that sleep is important, yet I am often dismaye...
Hurricane season officially ends this week. Thank goodness. Tampa Bay got lucky again — barely — but Hurricane Ian and then Nicole landed one-two punches on Florida and e...
In a first, the U.S. Food and Drug Administration has approved a therapy that slows the onset of Type 1 diabetes.
Teplizumab, developed by Provention Bio, typically dela...
Nine months into Russian President Vladimir Putin’s war in Ukraine, the damage done to the world’s 11th-largest economy is extensive. Leading Russian banks have been cut ...
In 1957, the decade-old Centers for Disease Control prohibited individuals under 21 from receiving vaccines during the major influenza epidemic of that year unless they h...
